APA (7th ed.) Citation

Gong, I. Y., & Kuruvilla, J. (2026). Management of relapsed/refractory DLBCL in the era of novel agents and new approaches. Leukemia & Lymphoma, 67(4), 756. https://doi.org/10.1080/10428194.2025.2599994

Chicago Style (17th ed.) Citation

Gong, Inna Y., and John Kuruvilla. "Management of Relapsed/refractory DLBCL in the Era of Novel Agents and New Approaches." Leukemia & Lymphoma 67, no. 4 (2026): 756. https://doi.org/10.1080/10428194.2025.2599994.

MLA (9th ed.) Citation

Gong, Inna Y., and John Kuruvilla. "Management of Relapsed/refractory DLBCL in the Era of Novel Agents and New Approaches." Leukemia & Lymphoma, vol. 67, no. 4, 2026, p. 756, https://doi.org/10.1080/10428194.2025.2599994.